Comera Life Sciences Holdings, Inc. (CMRA)
CMRA Stock Price Chart
Explore Comera Life Sciences Holdings, Inc. interactive price chart. Choose custom timeframes to analyze CMRA price movements and trends.
CMRA Company Profile
Discover essential business fundamentals and corporate details for Comera Life Sciences Holdings, Inc. (CMRA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
21 Dec 2020
Employees
12.00
Website
https://comeralifesciences.comCEO
Michael G. Campbell CPA
Description
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
CMRA Financial Timeline
Browse a chronological timeline of Comera Life Sciences Holdings, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 9 Nov 2023
EPS came in at -$0.10 , while revenue for the quarter reached $136.31K .
Earnings released on 10 Aug 2023
EPS came in at -$0.08 , while revenue for the quarter reached $315.06K .
Earnings released on 11 May 2023
EPS came in at -$0.13 , while revenue for the quarter reached $392.92K .
Earnings released on 16 Mar 2023
EPS came in at -$0.18 , while revenue for the quarter reached $156.12K .
Earnings released on 10 Nov 2022
EPS came in at -$0.20 , while revenue for the quarter reached $234.92K .
Earnings released on 10 Aug 2022
EPS came in at -$1.74 , while revenue for the quarter reached $146.73K .
Earnings released on 31 Mar 2022
EPS came in at -$0.17 , while revenue for the quarter reached $95.33K .
Earnings released on 31 Dec 2021
EPS came in at -$0.07 , while revenue for the quarter reached $319.83K .
Earnings released on 30 Sept 2021
EPS came in at -$0.05 , while revenue for the quarter reached $87.77K .
Earnings released on 30 Jun 2021
EPS came in at -$0.10 , while revenue for the quarter reached $70.92K .
CMRA Stock Performance
Access detailed CMRA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.